USDA Invests in Poultry Vaccine for Bird Flu

Vaccination Strategy Could Support Food Supply and Reduce Outbreaks

The U.S. Department of Agriculture (USDA) has allocated $100 million toward researching and developing a vaccine to combat Highly Pathogenic Avian Influenza (HPAI).

The disease has affected flocks across the country, but current infection rates are decreasing due to the slower migration season.

Introducing a poultry vaccine could significantly reduce outbreaks and support the continuity of food supply chains. Globally, more than 30 countries have used bird flu vaccines since 2005.

These efforts often come with trade complications, as importing countries fear vaccinated birds might still transmit the virus.

Another concern is the complexity of administering the vaccine. Existing options require two or three injections per bird, which presents serious labour challenges given the U.S. has around 375 million laying hens. The scale of such an operation is currently not feasible without alternative vaccination methods.

USDA's investment aims to support scientists and researchers in creating more efficient vaccines that reduce the need for multiple doses and can be delivered in a less labour-intensive way. Such advancements would make widespread vaccination more realistic and cost-effective.

Officials stress that any strategy must consider trade policies and ensure the U.S. maintains strong relationships with poultry importers. Balancing animal health, economic viability, and global trade will be key to implementing any nationwide vaccination plan.

“President Trump has directed his cabinet to unleash domestic production of our natural resources, including timber. Our nation is blessed with an abundance of resources and there is no reason we cannot responsibly harvest and use these products right here at home,” said Secretary Rollins.

With the USDA's support, a safe and efficient vaccine could become a critical tool in reducing the impact of bird flu and safeguarding the nation’s food systems.